These results are complementing those of other studies [40], where Birinapant in combination with TNF-a exhibits a strong anti-melanoma effect in vitro and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism [41]. This evidence concerns the gene TNFSF10 and melanoma.